Tisotumab vedotin
| Tisotumab vedotin | |
|---|---|
| Term | Tisotumab vedotin |
| Short definition | tisotumab vedotin - (pronounced) (ty-SOH-too-mab Veh-DOH-tin) drug used to treat adults with cervical cancer that has come back or spread. It is used in patients whose cancer has gotten worse during or after chemotherapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
tisotumab vedotin - (pronounced) (ty-SOH-too-mab Veh-DOH-tin) drug used to treat adults with cervical cancer that has come back or spread. It is used in patients whose cancer has gotten worse during or after chemotherapy. It is also being studied in the treatment of other types of cancer. Tisotumab Vedotin contains a monoclonal antibody that attaches to a protein called tissue factor, which is found on some cancer cells. It also contains a cancer drug that can help kill cancer cells. Tisotumab Vedotin can also prevent the growth of new blood vessels that tumors need to grow. It's a type of antibody-drug conjugate and a type of anti-angiogenesis drug. Also called Tivdak
External links
- Medical encyclopedia article on Tisotumab vedotin
- Wikipedia's article - Tisotumab vedotin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski